|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for CERS6 |
Top |
Phenotypic Information for CERS6(metabolism pathway, cancer, disease, phenome) |
Cancer Description | |
Cancer | CGAP: CERS6 |
Familial Cancer Database: CERS6 |
* This gene is included in those cancer gene databases. |
. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
Metabolic Pathway Description | |
REACTOME_PHOSPHOLIPID_METABOLISM REACTOME_SPHINGOLIPID_METABOLISM REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS |
Others | |
OMIM | |
Orphanet | |
Disease | KEGG Disease: CERS6 |
MedGen: CERS6 (Human Medical Genetics with Condition) | |
ClinVar: CERS6 | |
Phenotype | MGI: CERS6 (International Mouse Phenotyping Consortium) |
PhenomicDB: CERS6 |
Mutations for CERS6 |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
Structural Variants in COSMIC: go to COSMIC mutation histogram |
- Statistics for Tissue and Mutation type | Top |
- For Inter-chromosomal Variations |
There's no inter-chromosomal structural variation. |
- For Intra-chromosomal Variations |
* Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'. |
Sample | Symbol_a | Chr_a | Start_a | End_a | Symbol_b | Chr_b | Start_b | End_b |
ovary | CERS6 | chr2 | 169524445 | 169524465 | CERS6 | chr2 | 169524531 | 169524551 |
pancreas | CERS6 | chr2 | 169578053 | 169578073 | CERS6 | chr2 | 169578116 | 169578136 |
cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract) |
Related fusion transcripts : go to Chitars2.0 |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows CERS6 related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
BE815041 | CERS6 | 29 | 131 | 2 | 169630062 | 169630167 | SPP1 | 131 | 266 | 4 | 88904333 | 88904468 | |
AW601963 | CERS6 | 5 | 299 | 2 | 169629012 | 169629307 | TXNIP | 300 | 580 | 1 | 145440113 | 145440522 | |
AW601881 | TXNIP | 11 | 482 | 1 | 145440113 | 145440935 | CERS6 | 483 | 624 | 2 | 169629012 | 169629156 | |
M86087 | LRFN5 | 1 | 75 | 14 | 42361011 | 42361085 | CERS6 | 76 | 205 | 2 | 169587955 | 169588084 | |
BF209028 | MEST | 501 | 571 | 7 | 130146084 | 130146155 | CERS6 | 563 | 582 | 2 | 169374239 | 169374258 | |
BI050759 | CERS6 | 25 | 209 | 2 | 169326774 | 169326958 | SVIL | 191 | 419 | 10 | 29839535 | 29839764 | |
BE085594 | CERS6 | 12 | 107 | 2 | 169406305 | 169406402 | QSER1 | 100 | 166 | 11 | 32926552 | 32926618 |
Other DBs for Structural Variants |
Top |
Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample | 2 |   |   | 1 |   |   |   |   | 1 |   |   |   |   |   |   | 1 |   | |||
GAIN (# sample) | 2 |   |   | 1 |   |   |   |   | 1 |   |   |   |   |   |   | 1 |   | |||
LOSS (# sample) |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
Top |
Somatic Mutation Counts per Tissue in COSMIC data |
Stat. for Non-Synonymous SNVs (# total SNVs=0) | (# total SNVs=0) |
(# total SNVs=0) | (# total SNVs=0) |
Top |
Top 10 SNVs Having the Most Samples in COSMIC data |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
Top |
SNV Counts per Each Loci in TCGA data |
|
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample | 1 | 1 |   | 4 | 1 |   | 1 |   | 2 | 1 |   | 5 | 1 |   |   |   | 7 | 2 | 1 | 6 |
# mutation | 1 | 1 |   | 5 | 1 |   | 1 |   | 2 | 1 |   | 6 | 1 |   |   |   | 8 | 2 | 1 | 6 |
nonsynonymous SNV | 1 | 1 |   | 5 | 1 |   | 1 |   | 2 | 1 |   | 4 | 1 |   |   |   | 2 | 2 | 1 | 4 |
synonymous SNV |   |   |   |   |   |   |   |   |   |   |   | 2 |   |   |   |   | 6 |   |   | 2 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
Top 10 SNVs Having the Most Samples in TCGA data |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr2:169571586 | p.F32F,CERS6 | 1 |
chr2:169313014 | p.V214A,CERS6 | 1 |
chr2:169626093 | p.A362A,CERS6 | 1 |
chr2:169547564 | p.P33Q,CERS6 | 1 |
chr2:169571606 | p.F217L,CERS6 | 1 |
chr2:169313054 | p.A35V,CERS6 | 1 |
chr2:169626103 | p.A228T,CERS6 | 1 |
chr2:169547576 | p.D37Y,CERS6 | 1 |
chr2:169571631 | p.A228V,CERS6 | 1 |
chr2:169313056 | p.P62P,CERS6 | 1 |
Other DBs for Point Mutations |
Copy Number for CERS6 in TCGA |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for CERS6 |
Gene Expression in Cancer Cell-lines (CCLE) |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
Differential Gene Expression in Primary Tumors (TCGA) |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
Top |
CNV vs Gene Expression Plot |
* This plots show the correlation between CNV and gene expression. |
Top |
Gene-Gene Network Information |
Co-Expressed gene's network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
AFF4,ARID2,CCNT1,DMXL1,DNAJB14,KIAA0232,LARP4, CERS6,LCOR,LMBRD2,LRBA,RAPGEF6,RSC1A1,SPOPL, STAM2,UBR1,UBR3,UEVLD,UHMK1,VEZF1,WDFY3 | ANKRD50,ARID2,ATP7A,AVL9,SMIM14,DCAF10,ERO1LB, FAM73A,FRS2,KIAA1958,CERS6,MAP9,PANK3,PEX1, RALGAPB,SGPL1,SLC35A3,ZMYM2,ZNF281,ZNF587,ZNF678 |
ASXL2,ATF2,C9orf129,DDI2,DENND4C,GMCL1,INADL, KIAA1715,CERS6,LATS1,PUM1,RAPGEF6,RC3H2,RIF1, SERINC5,STRN,STT3B,TGFBRAP1,UBR3,UGGT1,UHMK1 | ABLIM1,ARHGAP32,ATP7B,CASK,CMTM4,DOPEY2,GOLIM4, IGF2BP2,KIAA0319L,KIAA1804,CERS6,MYO10,NEO1,PDXDC1, PTPRK,RNF43,SH3RF2,SLC39A11,SSTR1,THSD4,XYLB |
Co-Expressed gene's Protein-protein interaction Network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
Interacting Genes (from Pathway Commons) |
Top |
Pharmacological Information for CERS6 |
There's no related Drug. |
Top |
Cross referenced IDs for CERS6 |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |